NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank20
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-203.82M
↓ 76% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-115.63M
Historical baseline
PeriodValueYoY Change
2025$-203.82M+15.6%
2024$-241.60M-36.5%
2023$-176.94M-681.7%
2022$-22.63M+45.8%
2021$-41.78M-495.0%
2020$-7.02M-